US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist
  • 4.2499
  • +0.2399+5.98%
Close Apr 26 16:00 ET
39.21MMarket Cap-556P/E (TTM)

SAB Biotherapeutics Key Stats

SAB Biotherapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

305.01K

-85.88%
EPS(YoY)

-3.84

-112.15%

Buy

Apr 4, 2024

SAB Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q4305.010K / 0.000--
--2023/Q31.267M / 13.330K--
--2023/Q285.520K / 406.670K--
--2023/Q1581.100K / 2.526M--
--2022/Q42.161M / 6.503M--
--2022/Q33.590M / 6.855M--
--2022/Q26.351M / 10.800M--
--2022/Q111.803M / 11.480M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q4305.010K / 0.000--
--2023/Q31.267M / 13.330K--
--2023/Q285.520K / 406.670K--
--2023/Q1581.100K / 2.526M--
--2022/Q42.161M / 6.503M--
--2022/Q33.590M / 6.855M--
--2022/Q26.351M / 10.800M--
--2022/Q111.803M / 11.480M--

Unlock Free Earnings Estimates

SAB Biotherapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 4, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg